Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Rx Patent Cases For Five Drugs Could Lead To Delayed Generics - FDA

Related Content

FDA "Slowdown" Not Shown By Data, But CBER Could Be Affected - Henney

Jun 18 2001

Generic Reform Advocates See Reimport Bill As Model: Is Hatch Obstacle?

May 14 2001

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window